论文部分内容阅读
目的观察胺碘酮联合美托洛尔静脉注射治疗快速心律失常的效果。方法将120例冠心病心律失常患者随机分为观察组和对照组各60例。观察组采用胺碘酮联合美托洛尔静脉注射治疗,对照组给予胺碘酮治疗。对比2组患者在72h内的临床疗效、住院病死率、胸痛复发率和治疗前后心室率。结果观察组的总有效率高于对照组,病死率、胸痛复发率低于对照组,差异均有统计学意义(P<0.05);治疗前2组心室率比较差异无统计学意义(P>0.05),治疗后2组心室率均低于治疗前,且观察组低于对照组,差异均有统计学意义(P<0.05)。结论在冠心病快速心律失常的临床治疗中,给予胺碘酮联合美托洛尔静脉注射治疗,取得了良好的临床效果,值得推广。
Objective To observe the effect of intravenous amiodarone combined with metoprolol in the treatment of tachyarrhythmia. Methods A total of 120 patients with coronary heart disease and arrhythmia were randomly divided into observation group (60 cases) and control group (60 cases). The observation group was treated with amiodarone combined with metoprolol intravenously and the control group with amiodarone. The clinical efficacy, hospital mortality, chest pain recurrence rate and ventricular rate before and after treatment in two groups were compared. Results The total effective rate of the observation group was higher than that of the control group, and the mortality and recurrence rate of chest pain were lower than those of the control group (P <0.05). There was no significant difference in ventricular rate between the two groups before treatment (P> 0.05). After treatment, the ventricular rate was lower in both groups than before treatment, and the observation group was lower than that in the control group. The differences were statistically significant (P <0.05). Conclusions In the clinical treatment of tachyarrhythmia of coronary heart disease, amiodarone combined with metoprolol intravenous injection has achieved good clinical effect and is worth promoting.